miRNAs may play a major role in the control of gene expression in key pathobiological processes in Chagas disease cardiomyopathy

Chronic Chagas Disease Cardiomyopathy (CCC), a very aggressive cardiomyopathy of inflammation caused by a lifetime infection with the Protozoa Trypanosoma Cruzi, is the main cause of cardiomyopathy in Latin America. Although chronic myocarditis can play the main pathogenetic role, a little known about the molecular mechanism responsible for its severity. The purpose of this study was to study micrornas genes and expressions in their networks and connections in connection with the pathobiological process. To do this, we are integrated for the first time a global microrna expression and MRNA from the CCC patient’s myocardial network that uses pathways and network analysis. We observe enrichment in biological processes and lines related to immune response and metabolism. IFNγ, TNF and NFKB are top upstream regulators.

The intersection between Micrornas disclosed differently and the MRNAS target expressed differently shows enrichment in biological processes such as inflammation, inflammation, genes, fibrosis, hypertrophy, and mitochondrofil / oxidative antioxidant response. Micrornas also plays a role in gene expression regulations involved in the process related to cardiomyopathy related to fibrosis, hypertrophy, myocarditis and arrhythmias. Significantly, the number of discrete micrillah which is expressed differently targets the high number of MRNAS expressed differently (> 20) in several processes. Our results show that MInnas orkestrate expression is a lot of genes in the main pathophysiological process in CCC’s heart tissue. It may have pads on pathogenesis, biomarkers and therapy.

Impact of zinc oxide nanoparticles in cytotoxicity, genotoxicity, and Mirna expression in Barley (Hordeum Vulgare L.) Seeds

Nanoparticles Zinc oxide is one of the most commonly engineered nanomaterials and must enter the environment because of the large amount produced and the application is widespread. Understanding the impact of nanoparticles in plant growth and development is very important for assessing possible environmental risks to food security and human health, because plants are a basic component of living from ecosystems and the most important sources in the human food chain.

The purpose of this study was to examine the impact of various concentrations of zinc oxide nanoparticles in the seed germination of Barley Hordeum L. seeds, seed morphology, root cell viability, stress level, genotoxicity, and MIRNAS’s expression. The results showed that zinc oxide nanoparticles increased barley seed germination, climbing / root lengthening, and H2O2 stress levels and reduced the root cell viability and stability of the Genome and MIRNAS templates and downregated in wheat seeds.

Mirna’s dynamics mediate legume symbiosis regulations

Fixation of symbiotic nitrogen in legal nodules is important in land with low nitrogen availability. Symbiosis initiation and sustainability requires cellular reprogramming that involves inhibition of minna or activation of certain nodulation genes. High sementing from a small RNA library has identified the MIRNAS and their target, which is a major player in the post-transcription gene regulation (PTGS) from various stages of legum-rhizobia symbiosis ranging from bacterial and organogenesis colonization to symbiotic nitrogen fixation. Here we present an overview of information obtained from the Mirna Library from the sorted nodulation network to date.

MIRNAS’s functional analysis has revealed the role in phytohormone homeostasis and spatio-temporal regulations, as well as MIRNAS mobility and its function in root signaling that affects various functions, including bacterial entries, meristem divisions, nitrogen and aging fixation. Furthermore, the small RNA fragment from Rhizobial from pressing MRNA complementary plants. We also consider the role of MIRNAS in determining decisive or uncertain nodules. Taken together, this overview confirms that MIRNAS is the main regulator of the symbiosis of Legum-Rhizobia. This article is protected by copyright. All copyrights.

Identification and validation of the MIRNAS key and microrna-mrna settings networks related to ulcerative colitis

Olcerativa (UC) colitis is a chronic intestinal inflammatory disease, not specific, which involves various genes and paths in their pathogenesis. The current study reveals the main MIRNAS and network regulation of potential target genes as a model to predict the UC molecular mechanism. This can provide new insights to uncover UC pathogenesis. Differential declares MIRNAS (Demis) and MRNA (DEGS] which are expressed differently between UC patients and normal control of discretion using the omnibus database of gene expression. The target gene to be predicted to use the MIRDB, Mirwalk, Starbase, Tarbase and TargetScan data basis, and the Mirna network -MRNA was formed using the DEG which was changed in the opposition to Demis.

10X PBS MaxTag Histo (OKRA00043)

OKRA00043 100 ml
EUR 140
Description: Description of target: ;Species reactivity: ;Application: ;Assay info: ;Sensitivity:

10X PBS Buffer , pH 7.4, Refill Pack

P2100-204 3.5L
EUR 138

10X PBS Buffer , pH 7.4, Refill Pack

P2100-208 8L
EUR 219

SEAP (TetCMV, Puro) in PBS

LVP1184-PBS 1x107 IFU/ml x 200ul
EUR 710
Description: Concentrated Lentivirus express SEAP under optional inducible TetCMV promoter, containing puromycin selection.

SEAP (TetCMV, Bsd) in PBS

LVP1185-PBS 1x107 IFU/ml x 200ul
EUR 710
Description: Concentrated Lentivirus express SEAP under optional inducible TetCMV promoter, containing Blasticidin selection.

SEAP (TetCMV, Neo) in PBS

LVP1186-PBS 1x107 IFU/ml x 200ul
EUR 710
Description: Concentrated Lentivirus express SEAP under optional inducible TetCMV promoter, containing Neomycin selection.

SEAP (TetCMV, Hygro) in PBS

LVP1191-PBS 1x107 IFU/ml x 200ul
EUR 710
Description: Concentrated Lentivirus express SEAP under optional inducible TetCMV promoter, containing Hygromycin selection.

SEAP (TetCMV, Zeo) in PBS

LVP1192-PBS 1x107 IFU/ml x 200ul
EUR 710
Description: Concentrated Lentivirus express SEAP under optional inducible TetCMV promoter, containing Zeomycin selection.

SEAP (EF1a, Puro) in PBS

LVP1193-PBS 1x107 IFU/ml x 200ul
EUR 710
Description: Concentrated Lentivirus express SEAP under EF1a promoter, containing puromycin selection.

SEAP (EF1a, Bsd) in PBS

LVP1194-PBS 1x107 IFU/ml x 200ul
EUR 710
Description: Concentrated Lentivirus express SEAP under EF1a promoter, containing Blasticidin selection.

SEAP (EF1a, Neo) in PBS

LVP1195-PBS 1x107 IFU/ml x 200ul
EUR 710
Description: Concentrated Lentivirus express SEAP unde EF1a promoter, containing Neomycin selection.

SEAP (EF1a, Hygro) in PBS

LVP1200-PBS 1x107 IFU/ml x 200ul
EUR 710
Description: Concentrated Lentivirus express SEAP under EF1a promoter, containing Hygromycin selection.

SEAP (EF1a, Zeo) in PBS

LVP1201-PBS 1x107 IFU/ml x 200ul
EUR 710
Description: Concentrated Lentivirus express SEAP under EF1a promoter, containing Zeomycin selection.

SEAP (CAG, Puro) in PBS

LVP1202-PBS 1x107 IFU/ml x 200ul
EUR 710
Description: Concentrated Lentivirus express SEAP under CAG promoter, containing puromycin selection.

SEAP (CAG, Bsd) in PBS

LVP1203-PBS 1x107 IFU/ml x 200ul
EUR 710
Description: Concentrated Lentivirus express SEAP under CAG promoter, containing Blasticidin selection.

SEAP (CAG, Neo) in PBS

LVP1204-PBS 1x107 IFU/ml x 200ul
EUR 710
Description: Concentrated Lentivirus express SEAP unde CAG promoter, containing Neomycin selection.

SEAP (TetCMV, GFP) in PBS

LVP1215-PBS 1x107 IFU/ml x 200ul
EUR 710
Description: Concentrated Lentivirus express SEAP under optional inducible TetCMV promoter with GFP fluorescent marker.

SEAP (TetCMV, RFP) in PBS

LVP1216-PBS 1x107 IFU/ml x 200ul
EUR 710
Description: Concentrated Lentivirus express SEAP under optional inducible TetCMV promoter with RFP fluorescent marker.

SEAP (EF1a, GFP) in PBS

LVP1217-PBS 1x107 IFU/ml x 200ul
EUR 710
Description: Concentrated Lentivirus express SEAP under EF1a promoter with GFP fluorescent marker.

SEAP (EF1a, RFP) in PBS

LVP1218-PBS 1x107 IFU/ml x 200ul
EUR 710
Description: Concentrated Lentivirus express SEAP under EF1a promoter with RFP fluorescent marker.

SEAP (Ubc, Puro) in PBS

LVP1219-PBS 1x107 IFU/ml x 200ul
EUR 710
Description: Concentrated Lentivirus express SEAP under Ubc promoter, containing puromycin selection.

SEAP (mPGK, Puro) in PBS

LVP1220-PBS 1x107 IFU/ml x 200ul
EUR 710
Description: Concentrated Lentivirus express SEAP under mPGK promoter, containing puromycin selection.

SEAP (ActB, Puro) in PBS

LVP1221-PBS 1x107 IFU/ml x 200ul
EUR 710
Description: Concentrated Lentivirus express SEAP under ActB promoter, containing puromycin selection.

PBS 10X (WITHOUT CALCIUM AND MAGNESIUM, PH 7,4)

46-013-CM 1L/pk
EUR 90
Description: Media Catalog; Buffered Salt-Salution

SEAP (TetCMV, RFP-Bsd) in PBS

LVP1187-PBS 1x107 IFU/ml x 200ul
EUR 710
Description: Concentrated Lentivirus express SEAP under optional inducible TetCMV promoter with RFP fluorescent marker, containing Blasticidin selection.

SEAP (TetCMV, RFP-Puro) in PBS

LVP1188-PBS 1x107 IFU/ml x 200ul
EUR 710
Description: Concentrated Lentivirus express SEAP under optional inducible TetCMV promoter with RFP fluorescent marker, containing Puromycin selection.

SEAP (TetCMV, GFP-Bsd) in PBS

LVP1189-PBS 1x107 IFU/ml x 200ul
EUR 710
Description: Lentivirus express SEAP under optional inducible TetCMV promoter with GFP fluorescent marker, containing Blasticidin selection.

SEAP (TetCMV, GFP-Puro) in PBS

LVP1190-PBS 1x107 IFU/ml x 200ul
EUR 710
Description: Concentrated Lentivirus express SEAP under optional inducible TetCMV promoter with GFP fluorescent marker, containing Puromycin selection.

SEAP (EF1a, RFP-Bsd) in PBS

LVP1196-PBS 1x107 IFU/ml x 200ul
EUR 710
Description: Concentrated Lentivirus express SEAP under EF1a promoter with RFP fluorescent marker, containing Blasticidin selection.

SEAP (EF1a, RFP-Puro) in PBS

LVP1197-PBS 1x107 IFU/ml x 200ul
EUR 710
Description: Concentrated Lentivirus express SEAP under EF1a promoter with RFP fluorescent marker, containing Puromycin selection.

SEAP (EF1a, GFP-Bsd) in PBS

LVP1198-PBS 1x107 IFU/ml x 200ul
EUR 710
Description: Concentrated Lentivirus express SEAP under EF1a promoter with GFP fluorescent marker, containing Blasticidin selection.

SEAP (EF1a, GFP-Puro) in PBS

LVP1199-PBS 1x107 IFU/ml x 200ul
EUR 710
Description: Concentrated Lentivirus express SEAP under EF1a promoter with GFP fluorescent marker, containing Puromycin selection.

SEAP (CAG, RFP-Bsd) in PBS

LVP1205-PBS 1x107 IFU/ml x 200ul
EUR 710
Description: Concentrated Lentivirus express SEAP under CAG promoter with RFP fluorescent marker, containing Blasticidin selection.

SEAP (CAG, RFP-Puro) in PBS

LVP1206-PBS 1x107 IFU/ml x 200ul
EUR 710
Description: Concentrated Lentivirus express SEAP under CAG promoter with RFP fluorescent marker, containing Puromycin selection.

SEAP (CAG, GFP-Bsd) in PBS

LVP1207-PBS 1x107 IFU/ml x 200ul
EUR 710
Description: Concentrated Lentivirus express SEAP under CAG promoter with GFP fluorescent marker, containing Blasticidin selection.

SEAP (CAG, GFP-Puro) in PBS

LVP1208-PBS 1x107 IFU/ml x 200ul
EUR 710
Description: Concentrated Lentivirus express SEAP under CAG promoter with GFP fluorescent marker, containing Puromycin selection.

CRE (Neo), CMV lentivirus, in PBS 

LVP297-PBS 5 x107 IFU/ml x 200ul
EUR 710
Description: Pre-made lentiviral particles expressing nuclear permeable CRE recombinase with Neomycin marker. Virus concentrated and buffer changed into provided in PBS solution

lacZ (Neo) lentiviral particles in PBS

LVP333-PBS 5x107 IFU/ml x 200ul
EUR 710
Description: Concentrated lentiviral particles expressing full length lacZ enzyme (β-Galactosidase) with Neomycin marker, provided in PBS solution.

CRE (Bsd), CMV lentivirus in PBS 

LVP336-PBS 5 x107 IFU/ml x 200ul
EUR 710
Description: Pre-made lentiviral particles expressing nuclear permeable CRE recombinase with Blasticidin marker. Virus concentrated and buffer changed into provided in PBS solution

CRE (Puro), CMV lentivirus in PBS 

LVP339-PBS 5 x107 IFU/ml x 200ul
EUR 710
Description: Pre-made lentiviral particles expressing nuclear permeable CRE recombinase with puromycin marker. Virus concentrated and buffer changed into provided in PBS solution

CRE (Bsd), EF1a lentivirus in PBS 

LVP519-PBS 5 x107 IFU/ml x 200ul
EUR 710
Description: Pre-made lentiviral particles expressing nuclear permeable CRE recombinase under EF1a promoter with Blasticidin marker. Virus concentrated and buffer changed into provided in PBS solution

CRE (Puro), EF1a lentivirus in PBS 

LVP520-PBS 5 x107 IFU/ml x 200ul
EUR 710
Description: Pre-made lentiviral particles expressing nuclear permeable CRE recombinase under EF1a promoter with puromycin marker. Virus concentrated and buffer changed into provided in PBS solution

CRE (Neo), EF1a lentivirus, in PBS 

LVP521-PBS 5 x107 IFU/ml x 200ul
EUR 710
Description: Pre-made lentiviral particles expressing nuclear permeable CRE recombinase under EF1a promoter with Neomycin marker. Virus concentrated and buffer changed into provided in PBS solution

niRFP (CMV, Puro) Lentivirus in PBS

LVP558-PBS 1x108 IFU/ml x 200ul
EUR 710
Description: Concentrated lentivirus express the human codon near infred RFP under CMV promoter, containing the Puromycin resistance

niRFP (CMV, Bsd) Lentivirus in PBS

LVP559-PBS 1x108 IFU/ml x 200ul
EUR 710
Description: Concentrated lentivirus express the human codon near infred RFP under CMV promoter, containing the Blasticidin resistance

niRFP (CMV, Neo) Lentivirus in PBS

LVP560-PBS 1x108 IFU/ml x 200ul
EUR 710
Description: Concentrated lentivirus express the human codon near infred RFP under CMV promoter, containing the Neomycin resistance

niRFP (EF1a, Bsd) Lentivirus in PBS

LVP562-PBS 1x108 IFU/ml x 200ul
EUR 710
Description: Concentrated lentivirus express the human codon near infred RFP under EF1a promoter, containing the Blasticidin resistance

niRFP (EF1a, Neo) Lentivirus in PBS

LVP563-PBS 1x108 IFU/ml x 200ul
EUR 710
Description: Concentrated lentivirus express the human codon near infred RFP under EF1a promoter, containing the Neomycin resistance

CRE (Puro), CAG lentivirus in PBS

LVP573-PBS 5 x107 IFU/ml x 200ul
EUR 710
Description: Pre-made lentiviral particles expressing nuclear permeable CRE recombinase under CAG promoter with puromycin marker. Virus concentrated and buffer changed into provided in PBS solution

CRE (Bsd), CAG lentivirus in PBS

LVP574-PBS 5 x107 IFU/ml x 200ul
EUR 710
Description: Pre-made lentiviral particles expressing nuclear permeable CRE recombinase under CAG promoter with Blasticidin marker. Virus concentrated and buffer changed into provided in PBS solution

CRE (Neo), CAG lentivirus, in PBS

LVP575-PBS 5 x107 IFU/ml x 200ul
EUR 710
Description: Pre-made lentiviral particles expressing nuclear permeable CRE recombinase under CAG promoter with Neomycin marker. Virus concentrated and buffer changed into provided in PBS solution

Phosphate Buffered Saline (PBS) 10x pH 7.4, 1000 ml

12-9423-5 1000 ml
EUR 99

GFP inducible control lentiviral particles in PBS

LVP024-PBS 5x107 IFU/ml x 200ul
EUR 710
Description: Pre-made lentiviral particles expressing codon optimized GFP under tetracycline inducible suCMV promoter. Particles contain a blasticidin-RFP fusion dual marker under the constitutive RSV promoter, provided in PBS solution

CRE (GFP-Puro), CAG lentivirus in PBS

LVP576-PBS 5 x107 IFU/ml x 200ul
EUR 710
Description: Pre-made lentiviral particles bicistronically express (under CAG promoter) nuclear permeable CRE recombinase and the GFP marker under the same suCAG promoter. A Puromycin marker was expressed under RSV promoter. Virus concentrated and buffer changed into PBS solution.

CRE (RFP-Bsd), CAG lentivirus in PBS

LVP577-PBS 5 x107 IFU/ml x 200ul
EUR 710
Description: Pre-made lentiviral particles bicistronically express (under CAG promoter) nuclear permeable CRE recombinase and the RFP marker under the same suCAG promoter. A Blasticidin marker was expressed under RSV promoter. Virus concentrated and buffer changed into PBS solution.

CRE (RFP-Puro), CAG lentivirus in PBS

LVP578-PBS 5 x107 IFU/ml x 200ul
EUR 710
Description: Pre-made lentiviral particles bicistronically express (under CAG promoter) nuclear permeable CRE recombinase and the RFP marker under the same suCAG promoter. A Puromycin marker was expressed under RSV promoter. Virus concentrated and buffer changed into PBS solution.

GFP (TetCMV-Puro) lentiviral particles in PBS

LVP800-PBS 1x108 IFU/ml x 200ul
EUR 710
Description: Pre-made lentiviral particles expressing eGFP with Puromycin antibiotic marker. Particles were concentrated and provided in PBS solution

RFP (TetCMV-Puro) lentiviral particles in PBS

LVP801-PBS 1x108 IFU/ml x 200ul
EUR 710
Description: Pre-made lentiviral particles expressing RFP with Puromycin antibiotic marker. Particles were concentrated and provided in PBS solution

CFP (TetCMV-Puro) lentiviral particles in PBS

LVP802-PBS 1x108 IFU/ml x 200ul
EUR 710
Description: Pre-made lentiviral particles expressing CFP with Puromycin antibiotic marker. Particles were concentrated and provided in PBS solution

BFP (TetCMV-Puro) lentiviral particles in PBS

LVP803-PBS 1x108 IFU/ml x 200ul
EUR 710
Description: Pre-made lentiviral particles expressing BFP with Puromycin antibiotic marker. Particles were concentrated and provided in PBS solution

CRE-2A-GFP, CMV lentivirus in PBS 

LVP804-PBS 5 x107 IFU/ml x 200ul
EUR 710
Description: Pre-made lentiviral particles bicistronically express individual nuclear permeable CRE recombinase and the GFP marker under the same suCMV promoter. No any antibioic selection marker. Virus concentrated and buffer changed into PBS solution.

CRE-2A-RFP, CMV lentivirus in PBS 

LVP805-PBS 5 x107 IFU/ml x 200ul
EUR 710
Description: Pre-made lentiviral particles bicistronically express individual nuclear permeable CRE recombinase and the RFP marker under the same suCMV promoter. No any antibioic selection marker. Virus concentrated and buffer changed into PBS solution.

AR-GFP (Bsd) Lentivirusin PBS

LVP912-B-PBS 1x108 IFU/ml x 200ul
EUR 710
Description: Pre-made lentivirus express GFP reporter under the minimal promoter contains 4 tandem repeats of Androgen Response Element (ARE). This lentivirus also contain the Blasticidin selection marker under RSV promoter. Lentivirus concentrated and provided in PBS solution.

ARE-GFP (Puro) Lentivirusin PBS

LVP981-P-PBS 1x108 IFU/ml x 200ul
EUR 710
Description: Pre-made lentivirus express GFP reporter under a minimal promoter that embedded 4 tandem repeats of antioxidant response element (ARE). This lentivirus also contain the puromycin selection marker under RSV promoter. Lentivirus concentrated and provided in PBS solution.

CRE-2A-RFP (Bsd), CMV lentivirus in PBS 

LVP013-PBS 5 x107 IFU/ml x 200ul
EUR 710
Description: Pre-made lentiviral particles bicistronically express individual nuclear permeable CRE recombinase and the RFP marker under the same suCMV promoter. A Blasticidin marker was expressed under RSV promoter. Virus concentrated and buffer changed into PBS solution.

CRE-2A-RFP (Neo), CMV lentivirus in PBS 

LVP027-PBS 5 x107 IFU/ml x 200ul
EUR 710
Description: Pre-made lentiviral particles bicistronically express individual nuclear permeable CRE recombinase and the RFP marker under the same suCMV promoter. A Neomycin marker was expressed under RSV promoter. Virus concentrated and buffer changed into PBS solution.

CRE-2A-GFP (Bsd), CMV lentivirus in PBS 

LVP337-PBS 5 x107 IFU/ml x 200ul
EUR 710
Description: Pre-made lentiviral particles bicistronically express individual nuclear permeable CRE recombinase and the GFP marker under the same suCMV promoter. A Blasticidin marker was expressed under RSV promoter. Virus concentrated and buffer changed into PBS solution.

CRE-2A-RFP (Puro), CMV lentivirus in PBS 

LVP338-PBS 5 x107 IFU/ml x 200ul
EUR 710
Description: Pre-made lentiviral particles bicistronically express individual nuclear permeable CRE recombinase and the RFP marker under the same suCMV promoter. A Puromycin marker was expressed under RSV promoter. Virus concentrated and buffer changed into PBS solution.

CRE-2A-GFP (Puro), CMV lentivirus in PBS 

LVP407-PBS 5 x107 IFU/ml x 200ul
EUR 710
Description: Pre-made lentiviral particles bicistronically express individual nuclear permeable CRE recombinase and the GFP marker under the same suCMV promoter. A Puromycin marker was expressed under RSV promoter. Virus concentrated and buffer changed into PBS solution.

CRE-2A-GFP (Neo), CMV lentivirus in PBS 

LVP408-PBS 5 x107 IFU/ml x 200ul
EUR 710
Description: Pre-made lentiviral particles bicistronically express individual nuclear permeable CRE recombinase and the GFP marker under the same suCMV promoter. A Neomycin marker was expressed under RSV promoter. Virus concentrated and buffer changed into PBS solution.

CRE-2A-RFP (Bsd), EF1a lentivirus in PBS 

LVP522-PBS 5 x107 IFU/ml x 200ul
EUR 710
Description: Pre-made lentiviral particles bicistronically express (under EF1a promoter) nuclear permeable CRE recombinase and the RFP marker under the same suEF1a promoter. A Blasticidin marker was expressed under RSV promoter. Virus concentrated and buffer changed into PBS solution.

CRE-2A-RFP (Puro), EF1a lentivirus in PBS 

LVP523-PBS 5 x107 IFU/ml x 200ul
EUR 710
Description: Pre-made lentiviral particles bicistronically express (under EF1a promoter) nuclear permeable CRE recombinase and the RFP marker under the same suEF1a promoter. A Puromycin marker was expressed under RSV promoter. Virus concentrated and buffer changed into PBS solution.

CRE-2A-RFP (Neo), EF1a lentivirus in PBS 

LVP524-PBS 5 x107 IFU/ml x 200ul
EUR 710
Description: Pre-made lentiviral particles bicistronically express (under EF1a promoter) nuclear permeable CRE recombinase and the RFP marker under the same suEF1a promoter. A Neomycin marker was expressed under RSV promoter. Virus concentrated and buffer changed into PBS solution.

CRE-2A-GFP (Bsd), EF1a lentivirus in PBS 

LVP525-PBS 5 x107 IFU/ml x 200ul
EUR 710
Description: Pre-made lentiviral particles bicistronically express (under EF1a promoter) nuclear permeable CRE recombinase and the GFP marker under the same suEF1a promoter. A Blasticidin marker was expressed under RSV promoter. Virus concentrated and buffer changed into PBS solution.

CRE-2A-GFP (Puro), EF1a lentivirus in PBS 

LVP526-PBS 5 x107 IFU/ml x 200ul
EUR 710
Description: Pre-made lentiviral particles bicistronically express (under EF1a promoter) nuclear permeable CRE recombinase and the GFP marker under the same suEF1a promoter. A Puromycin marker was expressed under RSV promoter. Virus concentrated and buffer changed into PBS solution.

CRE-2A-GFP (Neo), EF1a lentivirus in PBS 

LVP527-PBS 5 x107 IFU/ml x 200ul
EUR 710
Description: Pre-made lentiviral particles bicistronically express (under EF1a promoter) nuclear permeable CRE recombinase and the GFP marker under the same suCMV promoter. A Neomycin marker was expressed under RSV promoter. Virus concentrated and buffer changed into PBS solution.

T-Pro Washing buffer in PBS and Tween-20 (10X)

JB09-I003 500ml/BT
EUR 144

CD14-Rluc (Bsd) Lentivirus in PBS

LVP1000-B-PBS 1x108 IFU/ml x 200ul
EUR 710
Description: Pre-made lentivirus express Renilla luciferase reporter under the human CD14 promoter which demonstrates strongly upregulated expression during monocytic cell differentiation. This lentivirus also contain the Blasticidin selection marker under RSV promoter. Lentivirus concentrated and provided in PBS solution.

CD14-Rluc (GFP) Lentivirus in PBS

LVP1000-G-PBS 1x108 IFU/ml x 200ul
EUR 710
Description: Pre-made lentivirus express Renilla luciferase reporter under the human CD14 promoter which demonstrates strongly upregulated expression during monocytic cell differentiation. This lentivirus also contain the GFP selection marker under the consitutive RSV promoter. Lentivirus concentrated and provided in PBS solution.

CD14-Rluc (Neo) Lentivirus in PBS

LVP1000-N-PBS 1x108 IFU/ml x 200ul
EUR 710
Description: Pre-made lentivirus express Renilla luciferase reporter under the human CD14 promoter which demonstrates strongly upregulated expression during monocytic cell differentiation. This lentivirus also contain the Neomycin selection marker under RSV promoter. Lentivirus concentrated and provided in PBS solution.

CD14-Rluc (Puro) Lentivirus in PBS

LVP1000-P-PBS 1x108 IFU/ml x 200ul
EUR 710
Description: Pre-made lentivirus express Renilla luciferase reporter under the human CD14 promoter which demonstrates strongly upregulated expression during monocytic cell differentiation. This lentivirus also contain the puromycin selection marker under RSV promoter. Lentivirus concentrated and provided in PBS solution.

CD14-Rluc (RFP) Lentivirus in PBS

LVP1000-R-PBS 1x108 IFU/ml x 200ul
EUR 710
Description: Pre-made lentivirus express Renilla luciferase reporter under the human CD14 promoter which demonstrates strongly upregulated expression during monocytic cell differentiation. This lentivirus also contain the RFP selection marker under the constitutive RSV promoter. Lentivirus concentrated and provided in PBS solution.

CD43-GFP (Bsd) Lentivirus in PBS

LVP1001-B-PBS 1x108 IFU/ml x 200ul
EUR 710
Description: Pre-made lentivirus express GFP reporter under the human CD43 promoter which expressed on the surface of leukocytes and platelets.. This lentivirus also contain the Blasticidin selection marker under RSV promoter. Lentivirus concentrated and provided in PBS solution.

CD43-GFP (Neo) Lentivirus in PBS

LVP1001-N-PBS 1x108 IFU/ml x 200ul
EUR 710
Description: Pre-made lentivirus express GFP reporter under the human CD43 promoter which expressed on the surface of leukocytes and platelets.. This lentivirus also contain the Neomycin selection marker under RSV promoter. Lentivirus concentrated and provided in PBS solution.

CD43-GFP (Puro) Lentivirus in PBS

LVP1001-P-PBS 1x108 IFU/ml x 200ul
EUR 710
Description: Pre-made lentivirus express GFP reporter under the human CD43 promoter which expressed on the surface of leukocytes and platelets.. This lentivirus also contain the puromycin selection marker under RSV promoter. Lentivirus concentrated and provided in PBS solution.

CD43-GFP (RFP) Lentivirus in PBS

LVP1001-R-PBS 1x108 IFU/ml x 200ul
EUR 710
Description: Pre-made lentivirus express GFP reporter under the human CD43 promoter which expressed on the surface of leukocytes and platelets.. This lentivirus also contain the RFP selection marker under the constitutive RSV promoter. Lentivirus concentrated and provided in PBS solution.

CD43-RFP (Bsd) Lentivirus in PBS

LVP1002-B-PBS 1x108 IFU/ml x 200ul
EUR 710
Description: Pre-made lentivirus express RFP reporter under the human CD43 promoter which expressed on the surface of leukocytes and platelets.. This lentivirus also contain the Blasticidin selection marker under RSV promoter. Lentivirus concentrated and provided in PBS solution.

CD43-RFP (GFP) Lentivirus in PBS

LVP1002-G-PBS 1x108 IFU/ml x 200ul
EUR 710
Description: Pre-made lentivirus express RFP reporter under the human CD43 promoter which expressed on the surface of leukocytes and platelets.. This lentivirus also contain the GFP selection marker under the consitutive RSV promoter. Lentivirus concentrated and provided in PBS solution.

CD43-RFP (Neo) Lentivirus in PBS

LVP1002-N-PBS 1x108 IFU/ml x 200ul
EUR 710
Description: Pre-made lentivirus express RFP reporter under the human CD43 promoter which expressed on the surface of leukocytes and platelets.. This lentivirus also contain the Neomycin selection marker under RSV promoter. Lentivirus concentrated and provided in PBS solution.

CD43-RFP (Puro) Lentivirus in PBS

LVP1002-P-PBS 1x108 IFU/ml x 200ul
EUR 710
Description: Pre-made lentivirus express RFP reporter under the human CD43 promoter which expressed on the surface of leukocytes and platelets.. This lentivirus also contain the puromycin selection marker under RSV promoter. Lentivirus concentrated and provided in PBS solution.

CD43-Luc (Bsd) Lentivirus in PBS

LVP1003-B-PBS 1x108 IFU/ml x 200ul
EUR 710
Description: Pre-made lentivirus express Firefly luciferase reporter under the human CD43 promoter which expressed on the surface of leukocytes and platelets.. This lentivirus also contain the Blasticidin selection marker under RSV promoter. Lentivirus concentrated and provided in PBS solution.

CD43-Luc (GFP) Lentivirus in PBS

LVP1003-G-PBS 1x108 IFU/ml x 200ul
EUR 710
Description: Pre-made lentivirus express Firefly luciferase reporter under the human CD43 promoter which expressed on the surface of leukocytes and platelets.. This lentivirus also contain the GFP selection marker under the consitutiveRSV promoter. Lentivirus concentrated and provided in PBS solution.

CD43-Luc (Neo) Lentivirus in PBS

LVP1003-N-PBS 1x108 IFU/ml x 200ul
EUR 710
Description: Pre-made lentivirus express Firefly luciferase reporter under the human CD43 promoter which expressed on the surface of leukocytes and platelets.. This lentivirus also contain the Neomycin selection marker under RSV promoter. Lentivirus concentrated and provided in PBS solution.

CD43-Luc (Puro) Lentivirus in PBS

LVP1003-P-PBS 1x108 IFU/ml x 200ul
EUR 710
Description: Pre-madelentivirus express Firefly luciferase reporter under the human CD43 promoter which expressed on the surface of leukocytes and platelets.. This lentivirus also contain the puromycin selection marker under RSV promoter. Lentivirus concentrated and provided in PBS solution.

CD43-Luc (RFP) Lentivirus in PBS

LVP1003-R-PBS 1x108 IFU/ml x 200ul
EUR 710
Description: Pre-made lentivirus express Firefly luciferase reporter under the human CD43 promoter which expressed on the surface of leukocytes and platelets.. This lentivirus also contain the RFP selection marker under the constitutive RSV promoter. Lentivirus concentrated and provided in PBS solution.

CD43-Rluc (Bsd) Lentivirus in PBS

LVP1004-B-PBS 1x108 IFU/ml x 200ul
EUR 710
Description: Pre-made lentivirus express Renilla luciferase reporter under the human CD43 promoter which expressed on the surface of leukocytes and platelets.. This lentivirus also contain the Blasticidin selection marker under RSV promoter. Lentivirus concentrated and provided in PBS solution.

CD43-Rluc (GFP) Lentivirus in PBS

LVP1004-G-PBS 1x108 IFU/ml x 200ul
EUR 710
Description: Pre-made lentivirus express Renilla luciferase reporter under the human CD43 promoter which expressed on the surface of leukocytes and platelets.. This lentivirus also contain the GFP selection marker under the consitutive RSV promoter. Lentivirus concentrated and provided in PBS solution.

CD43-Rluc (Neo) Lentivirus in PBS

LVP1004-N-PBS 1x108 IFU/ml x 200ul
EUR 710
Description: Pre-made lentivirus express Renilla luciferase reporter under the human CD43 promoter which expressed on the surface of leukocytes and platelets.. This lentivirus also contain the Neomycin selection marker under RSV promoter. Lentivirus concentrated and provided in PBS solution.

CD43-Rluc (Puro) Lentivirus in PBS

LVP1004-P-PBS 1x108 IFU/ml x 200ul
EUR 710
Description: Pre-made lentivirus express Renilla luciferase reporter under the human CD43 promoter which expressed on the surface of leukocytes and platelets.. This lentivirus also contain the puromycin selection marker under RSV promoter. Lentivirus concentrated and provided in PBS solution.

CD43-Rluc (RFP) Lentivirus in PBS

LVP1004-R-PBS 1x108 IFU/ml x 200ul
EUR 710
Description: Pre-made lentivirus express Renilla luciferase reporter under the human CD43 promoter which expressed on the surface of leukocytes and platelets.. This lentivirus also contain the RFP selection marker under the constitutive RSV promoter. Lentivirus concentrated and provided in PBS solution.

CD45-GFP (Bsd) Lentivirus in PBS

LVP1005-B-PBS 1x108 IFU/ml x 200ul
EUR 710
Description: Pre-made lentivirus express GFP reporter under the human CD45's promoter which expressed exclusively by all hematopoietic cells except erythrocytes and platelets. This lentivirus also contain the Blasticidin selection marker under RSV promoter. Lentivirus concentrated and provided in PBS solution.

We verify the main expression of Demis in the UC model of rodents. The Mirna-MRNA network contains 31 Demis and 199 degrees, which show enrichment in inflammation of the intestinal Hub. In addition, we identify six Demis and genes from initial validation analysis in the network model. In the pathophysiological process of UC, various genes and proteins display differences of expressions and complex interactions with each other. This finding provides new insight into the potential key mechanism Related to UC development.

Leave A Comment